| RS1212157084 |
PLXNB2
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS1212171741 |
MYO5B
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital microvillous atrophy, Congenital microvillous atrophy |
| RS1212204584 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Cardiovascular phenotype |
| RS1212213363 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1212228078 |
PNKP
|
Health Risk |
Pathogenic |
PNKP-related disorder, PNKP-related disorder |
| RS1212229540 |
ATAD3A
|
Health Risk |
Likely pathogenic |
— |
| RS1212229943 |
LMOD3
|
Health Risk |
Pathogenic |
Nemaline myopathy 10, Nemaline myopathy 10 |
| RS1212231432 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1212235186 |
CPT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyl transferase II deficiency |
| RS1212259128 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS1212282286 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1212294259 |
VPS13B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Cohen syndrome |
| RS1212299137 |
CEP78
|
Health Risk |
Pathogenic |
— |
| RS1212299212 |
SLC12A3
|
Health Risk |
Pathogenic |
— |
| RS1212308982 |
OTOA
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 22, Autosomal recessive nonsyndromic hearing loss 22 |
| RS1212322787 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1212333772 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS12123397 |
NPHS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome, type 2 |
| RS1212374733 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1212378071 |
NIPAL4
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 6, Autosomal recessive congenital ichthyosis 6 |
| RS1212383243 |
AFG2B
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hearing loss and spasticity, Neurodevelopmental disorder with hearing loss and spasticity |
| RS1212402265 |
IL12RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS1212405193 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1212410709 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1212418813 |
ABCG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Sitosterolemia |
| RS1212420029 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1212443202 |
ACADM
|
Health Risk |
Conflicting classifications of pathogenicity |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Inborn genetic diseases |
| RS1212444447 |
HMGCL
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS1212452748 |
CTNNB1
|
Health Risk |
Likely pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS1212466958 |
ADA2
|
Health Risk |
Pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS1212479289 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS1212487109 |
PEX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder, Heimler syndrome 2 |
| RS1212509590 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |
| RS1212517874 |
GRIN1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS1212517901 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, Methylcrotonyl-CoA carboxylase deficiency |
| RS1212529394 |
CPT1A
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase 1A deficiency, Carnitine palmitoyl transferase 1A deficiency |
| RS1212535211 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1212547389 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1212552985 |
WASHC4
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 43 |
| RS1212577306 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1212577459 |
PIK3R2
|
Health Risk |
Likely pathogenic |
Multiple myeloma, Multiple myeloma |
| RS1212599579 |
TGFBR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Diabetic retinopathy |
| RS1212599937 |
CSPP1
|
Health Risk |
Pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS1212608410 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1212611138 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiac arrhythmia |
| RS1212620164 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1212623980 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, GNE myopathy |
| RS1212633515 |
ACP4
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta, type 1J |
| RS1212635015 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1212639017 |
MVK
|
Health Risk |
Conflicting classifications of pathogenicity |
Porokeratosis 3, disseminated superficial actinic type |
| RS1212640732 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1212642361 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS1212663056 |
TMEM43
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS1212676320 |
SPINK5
|
Health Risk |
Pathogenic/Likely pathogenic |
Ichthyosis linearis circumflexa, Netherton syndrome |
| RS1212696529 |
SLF2
|
Health Risk |
Pathogenic |
Atelis syndrome 1, Atelis syndrome 1 |
| RS1212700979 |
DYRK1A
|
Health Risk |
Conflicting classifications of pathogenicity |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1212701617 |
MTRR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblE, Neural tube defects |
| RS1212702104 |
NPHS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS1212705780 |
TUBB3
|
Health Risk |
Likely pathogenic |
— |
| RS1212706214 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Medulloblastoma, Gorlin syndrome |
| RS1212716750 |
HNF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cysts and diabetes syndrome, Maturity-onset diabetes of the young |
| RS1212717189 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |
| RS1212720647 |
ACADS
|
Health Risk |
Likely pathogenic |
Deficiency of butyryl-CoA dehydrogenase, Deficiency of butyryl-CoA dehydrogenase |
| RS1212739356 |
FRAS1
|
Health Risk |
Likely pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1212740618 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1212744203 |
FMO3
|
Health Risk |
Pathogenic |
— |
| RS1212768461 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1212773301 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1212780118 |
ASNS
|
Health Risk |
Likely pathogenic |
— |
| RS1212790997 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1212793496 |
MRPS34
|
Health Risk |
Pathogenic/Likely pathogenic |
MRPS34-related disorder, Inborn genetic diseases |
| RS1212794587 |
MLH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, hereditary nonpolyposis |
| RS1212796323 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS1212807954 |
RLBP1
|
Health Risk |
Pathogenic |
— |
| RS1212814399 |
NOTCH3
|
Health Risk |
Pathogenic |
— |
| RS1212837838 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated Nonsyndromic Congenital Heart Disease, Alagille syndrome due to a JAG1 point mutation |
| RS1212843827 |
RGS9
|
Health Risk |
Pathogenic |
— |
| RS1212877137 |
IHH
|
Health Risk |
Conflicting classifications of pathogenicity |
Brachydactyly type A1A, Brachydactyly type A1A |
| RS1212883982 |
GLS
|
Health Risk |
Pathogenic |
Global developmental delay, progressive ataxia |
| RS1212919060 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS1212920276 |
LMNA
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Emery-Dreifuss muscular dystrophy 2, autosomal dominant |
| RS1212933615 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1212937518 |
HPS6
|
Health Risk |
Pathogenic |
— |
| RS1212949833 |
PANX1
|
Health Risk |
Pathogenic |
Oocyte maturation defect 7, Oocyte maturation defect 7 |
| RS1212952550 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |
| RS1212979817 |
MFSD8
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS1212988348 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS1212996409 |
TP53
|
Health Risk |
Pathogenic |
Ovarian neoplasm, Ovarian neoplasm |
| RS1212998897 |
PDE6B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 40, Retinitis pigmentosa 40 |
| RS1212999117 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS1213017578 |
CTNNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1213042460 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS1213056420 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1213060424 |
DLG3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, DLG3-related disorder |
| RS1213073076 |
RARS2
|
Health Risk |
Likely pathogenic |
Nonpapillary renal cell carcinoma, Nonpapillary renal cell carcinoma |
| RS1213106224 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS1213117443 |
COL11A2
|
Health Risk |
Pathogenic |
— |
| RS1213124542 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, CEP290-related disorder |
| RS1213132001 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1213135480 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |